Home
E-Submission
Sitemap
Contact Us
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Principles of transparency and best practice
Management team
Open access
Subscription information
Contact us
BROWSE ARTICLES
All issues
Current issue
Ahead-of print articles
Most read articles
Most download articles
Most cited articles
Search
Author index
FOR AUTHORS AND REVIEWERS
Instructions for authors
Research and publication ethics
Author checklist
E-submission
Submission requirement form
Search
Search
Page Path
HOME
Search
Review Article
Peri-Operative Intravesical Chemotherapy in the Treatment of Non-Muscle Invasive Bladder Cancer: Is It Necessary?
Myong Kim , Ja Hyeon Ku
Korean J Urol Oncol.
2013;11(3):109-115. Published online December 30, 2013
PDF
Original Article
Comparison of 6 and 12 Core Transrectal Ultrasound Guided Prostate Biopsy for the Prostate Cancer Detection
Sang Wook Lee , Min Young Park , Ja Hyeon Ku , Cheol Kwak , Hyeon Jeong , Seung Hyup Kim , Eunsik Lee , Sang Eun Lee
Korean J Urol Oncol.
2004;2(3):161-165. Published online September 30, 2004
PDF
1
Journal of
Urologic Oncology
Print ISSN: 2951-603X
Online ISSN: 2982-7043
MOST READ
MOST CITED
5,749
New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
5,226
The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
4,596
An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
4,531
Complex Epidemiology of Prostate Cancer in Asian Countries
4,520
The Present and Future of Intravesical Therapy in Bladder Cancer
+more
Cited By
8
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By
4
An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By
4
Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By
3
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By
2
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
+more